Investigation of the Effect of Kinesiotape Applied With Exercise on Muscle Oxygenation With Moxy Muscle Oxygen Monitor

June 3, 2024 updated by: Fatma Nur YILMAZ, Bandırma Onyedi Eylül University
Kinesio taping (KT) is an elastic adhesive tape with physiological effects, often used in rehabilitation and sports medicine. KT, which can stay in the body for 3 to 5 days, exerts a pulling force on the skin thanks to its wave-like structure and elasticity, and increases the gap between the subcutaneous soft tissue and fascia with its lifting effect. In this way, it reduces the superficial pressure and causes an increase in lymph circulation. In addition, with the effect it creates on the muscles, it allows maximum contraction and relaxation of the muscle and creates positive effects on the deep lymphatics. Another effective approach to increase blood circulation is exercise. Exercise, which is known to have many benefits, has been shown to increase both systemic circulation and muscle blood flow. There are findings in the literature that KT can increase the effectiveness of exercise, but it has been stated that this issue is not clear and more studies are needed. In order to evaluate the effects of KT on increasing the effectiveness of exercise and on circulation, the oxygen saturation of the muscle in the application area can be measured. As a matter of fact, "Moxy muscle oxygen monitor" has been used in the literature, which measures regional oxygen saturation (SmO2) and total hemoglobin (THb) in capillaries under the muscle. The Moxy muscle oxygen monitor is a lightweight (42 g) and small (dimensions: 61 × 44 × 21 mm) device that measures regional blood flow and oxygenation by placing it on the skin non-invasively with near-infrared spectroscopy (NIRS). Its validity in measuring muscle oxygenation was vigorous or fairly good, and its reliability was found to be moderate to high in low-intensity exercises (SROC: r = 0.842-0.993, ICC: r = 0.773-0.992, p < .01). It is thought that the application of KT, which is known to increase lymphatic and venous circulation, together with exercise will increase the amount of oxygen in the muscles. To the best of our knowledge in the literature, no study has been found in which this effect of KT is presented objectively. For this reason, it is aimed to examine muscle oxygenation with the Moxy muscle oxygen monitor, which provides objective data on KT applied with exercise.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bandırma
      • Balıkesir, Bandırma, Turkey
        • Bandırma Onyedi Eylül University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Volunteering to participate in the study
  • Being between the ages of 18-40
  • Being sedentary (<600 MET-min/week according to the International Physical Activity Questionnaire Short Form)
  • BMI <30kg/cm2
  • Subcutaneous fat thickness <12mm

Exclusion Criteria:

  • Having an open wound or infection in the application area
  • Having a chronic illness
  • Being pregnant
  • Having a psychological disorder
  • Having a lower extremity injury in the last 6 months
  • Having had any surgical operation involving the lower extremity in the last 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Healthy sedentary people
Muscle oxygenation and vital signs will be measured before, during, and after of 20 minutes aerobic exercise in an environment where suitable conditions are provided. After 3 days, kinesio taping will be added to the same program and the measurements will be repeated.

Exercise: Aerobic exercise will be performed on the treadmill for 20 minutes with a maximum heart rate of 55%-65% and a perceived exertion of less than 3. The Moxy muscle oxygen monitor will take measurements over the quadriceps femoris muscle at this time.

Kinesiotaping: After 3 days, the same participants will be called for kinesiotaping application. The application will be applied to the quadriceps femoris muscle with the facilitation technique by a physiotherapist who has a kinesio taping training certificate.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Moxy Muscle Oxygen Monitor
Time Frame: Baseline
The Moxy muscle oxygen monitor is a lightweight (42 g) and small (dimensions: 61 × 44 × 21 mm) device that measures regional blood flow and oxygenation by placing it on the skin non-invasively with near infrared spectroscopy (NIRS). The device, which has data collection and telemetric features, also allows O2 measurement in non-laboratory environments and field-based research. Compared to other NIRS devices, the Moxy muscle oxygen monitor has been shown to be a valid and reliable device for muscle oxygenation. Its validity in measuring muscle oxygenation was strong or very good, and its reliability was found to be moderate to high in low-intensity exercises (SROC: r = 0.842-0.993, ICC: r = 0.773-0.992, p < .01). It has been reported that as exercise intensity increases, its reliability changes inversely.
Baseline
Moxy Muscle Oxygen Monitor
Time Frame: fourth day
The Moxy muscle oxygen monitor is a lightweight (42 g) and small (dimensions: 61 × 44 × 21 mm) device that measures regional blood flow and oxygenation by placing it on the skin non-invasively with near infrared spectroscopy (NIRS). The device, which has data collection and telemetric features, also allows O2 measurement in non-laboratory environments and field-based research. Compared to other NIRS devices, the Moxy muscle oxygen monitor has been shown to be a valid and reliable device for muscle oxygenation. Its validity in measuring muscle oxygenation was strong or very good, and its reliability was found to be moderate to high in low-intensity exercises (SROC: r = 0.842-0.993, ICC: r = 0.773-0.992, p < .01). It has been reported that as exercise intensity increases, its reliability changes inversely.
fourth day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
heart rate
Time Frame: Baseline
heart rate will be evaluated with pulse oximetry
Baseline
heart rate
Time Frame: fourth day
heart rate will be evaluated with pulse oximetry
fourth day

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
respiratory frequency
Time Frame: Baseline
respiratory frequency will be evaluated with pulse oximetry
Baseline
respiratory frequency
Time Frame: fourth day
respiratory frequency will be evaluated with pulse oximetry
fourth day
O2 saturation
Time Frame: Baseline
O2 saturation will be evaluated with pulse oximetry
Baseline
O2 saturation
Time Frame: fourth day
O2 saturation will be evaluated with pulse oximetry
fourth day
blood pressure
Time Frame: Baseline
blood pressure will be evaluated with sphygmomanometer. Systolic and diastolic pressures will be assessed.
Baseline
blood pressure
Time Frame: fourth day
blood pressure will be evaluated with sphygmomanometer. Systolic and diastolic pressures will be assessed.
fourth day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 16, 2021

Primary Completion (Actual)

March 1, 2023

Study Completion (Actual)

May 2, 2023

Study Registration Dates

First Submitted

June 2, 2022

First Submitted That Met QC Criteria

June 16, 2022

First Posted (Actual)

June 22, 2022

Study Record Updates

Last Update Posted (Estimated)

June 4, 2024

Last Update Submitted That Met QC Criteria

June 3, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2020-60

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on exercise and kinesiotaping

3
Subscribe